Xilio Therapeutics
34 hedge funds and large institutions have $9.1M invested in Xilio Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
6
Increased
8
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DF
26
Dunhill Financial
London,
United Kingdom
| $5.65K | 10,274 | +10,274 | New |
|
27
JPMorgan Chase & Co
New York
| $1.57K | 2,857 | +135 | +5% |
|
|
KFI
28
Key Financial Inc
West Chester,
Pennsylvania
| $456 | 830 | – | – |
|
29
UBS Group
Zurich,
Switzerland
| $111 | 201 | – | – |
|
30
Wells Fargo
San Francisco,
California
| $58 | 106 | +6 | +6% |
|
|
CFB
31
Cullen/Frost Bankers
San Antonio,
Texas
| $55 | 100 | – | – |
|
32
Bank of America
Charlotte,
North Carolina
| $6 | 11 | -226,708 | -100% |
|
33
Qube Research & Technologies (QRT)
London,
United Kingdom
| $2 | 4 | – | – |
|
|
HMC
34
Harvard Management Company
Boston,
Massachusetts
| – | – | -416,059 | Closed |
|
|
SCM
35
Soleus Capital Management
Greenwich,
Connecticut
| – | – | -226,941 | Closed |
|
36
Dimensional Fund Advisors
Austin,
Texas
| – | – | -26,449 | Closed |
|
|
CFGS
37
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 468 | +118 | +34% |
|